Millennium Management’s Mural Oncology MURA Stock Holding History

Millennium Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-258,487	Closed	-$535K	–	6306
2025 Q3	$535K	Sell	258,487 -57,553	-18%	-$124K	﹤0.01%	5025
2025 Q2	$781K	Buy	316,040 +147,039	+87%	+$347K	﹤0.01%	4595
2025 Q1	$213K	Buy	169,001 +746	+0.4%	+$2.72K	﹤0.01%	5279
2024 Q4	$542K	Sell	168,255 -20,963	-11%	-$73.9K	﹤0.01%	4691
2024 Q3	$592K	Buy	189,218 +32,623	+21%	+$106K	﹤0.01%	4696
2024 Q2	$492K	Buy	156,595 +96,141	+159%	+$354K	﹤0.01%	4598
2024 Q1	$296K	Sell	60,454 -160,987	-73%	-$782K	﹤0.01%	5149
2023 Q4	$1.31M	Buy	+221,441	New	+$890K	﹤0.01%	3942

Millennium Management's MURA Position: Q4 2025 in Review

Millennium Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 258,487 shares — an estimated $535K sold.

Millennium Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $1.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Millennium Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Millennium Management sold 258,487 Mural Oncology shares in Q4 2025, an estimated $535K.
Millennium Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Millennium Management's Mural Oncology position peaked at $1.31M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.